戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 but by concerned action and inextinguishable enthusiasm".
2  the infused cells themselves, have tempered enthusiasm.
3 oracic Surgery has progressed with warranted enthusiasm.
4 nosis has generated tremendous attention and enthusiasm.
5 brics to share understanding, resources, and enthusiasm.
6 ence for law has been touted with particular enthusiasm.
7                                 Despite such enthusiasm, a number of issues remain unresolved regardi
8                                     There is enthusiasm about the activity of temozolomide in the tre
9 se characteristics have generated tremendous enthusiasm about the potential applications of these cel
10                                      Despite enthusiasm about this unexpected efficacy of ketamine, i
11 to the same biology, but there is increasing enthusiasm among astronomers, astrobiologists, and synth
12                         Much of this renewed enthusiasm among clinicians is due to the increased usag
13 careers: 1) We must improve satisfaction and enthusiasm among generalist physician role models.
14  has failed to keep pace with investigators' enthusiasm and clinical resources.
15 cular biology techniques have also increased enthusiasm and feasibility for testing genetically engin
16 In contrast, patients expressed considerable enthusiasm and few fears, anticipating both improved und
17 t scientific advances have generated renewed enthusiasm and hope for universal vaccines that will ind
18  clinical trials have emerged, creating both enthusiasm and new challenges for the optimum clinical d
19        If medical educators seek to optimize enthusiasm and preparation for primary care careers, the
20                However, despite this initial enthusiasm and the plethora of available robotic technol
21 to-consumer device marketing, do-it-yourself enthusiasm, and an escalating number of clinical trials.
22  I worked hard, with a lot of dedication and enthusiasm, and I was there when the luck arrived.
23                                          The enthusiasm, apparently justified by the subsequent resul
24 no-associated virus (AAV) has generated much enthusiasm as a transfer vector for human gene therapy.
25 in organoid research has been met with great enthusiasm, as well as expectation, from the scientific
26               We found that, in this sample, enthusiasm at the beginning of internship soon gave way
27 now emerging, the results should be met with enthusiasm, but also with caution.
28  factor delivery resulted in a great deal of enthusiasm, but larger clinical studies have failed to a
29     Multiple ITA grafting was met with early enthusiasm by the surgical profession, but skepticism an
30                                         This enthusiasm creates an environment ripe for the premature
31            Despite scientific and commercial enthusiasm, easy answers (whether about antibiotics or p
32                                      Patient enthusiasm extended across age, education, and health st
33 ined periods of increasingly high energy and enthusiasm, first as an evangelist and then as an artist
34 ation type was independently associated with enthusiasm for "eliminating fee for service" (salary plu
35                                Few expressed enthusiasm for "eliminating fee-for-service payment mode
36                                              Enthusiasm for 17 cost-containment strategies and agreem
37 ary, preclinical studies continue to provide enthusiasm for 2ME2 as a broad-spectrum agent.
38 ic the virion surface molecule has increased enthusiasm for a neutralizing antibody (nAb)-based HIV v
39                                  Much of the enthusiasm for accountable care organizations is fueled
40 , endovascular repair has been embraced with enthusiasm for all prospective patients who are suitable
41                                Despite great enthusiasm for all things nanotubular and their potentia
42                Although initially promising, enthusiasm for apobec-1 gene therapy for hypercholestero
43                            There is a lot of enthusiasm for applying next-generation sequencing metho
44 ight lead to increased public engagement and enthusiasm for biodiversity.
45 e is a longstanding and recently rejuvenated enthusiasm for biomarkers that precisely and specificall
46              We were encouraged by the broad enthusiasm for building machines that learn and think in
47 ons changed late into residency training and enthusiasm for careers in general internal medicine rema
48 r cells that reside within the heart spurred enthusiasm for cell-based regenerative therapies.
49 llaborators in Edmonton, has revitalized the enthusiasm for cellular transplantation as a treatment f
50 ffects, my motivation is largely to share my enthusiasm for certain kinds of biological narratives, t
51 s is increasing worldwide and there is great enthusiasm for clinical use of advanced MRI-guided radio
52       We are concerned, however, that in our enthusiasm for collectively endorsing these guidelines,
53 initiatives to reduce cost but reported less enthusiasm for cost containment involving changes in pay
54 sepsis therapy has diminished pharmaceutical enthusiasm for developing novel drugs for the treatment
55 coid agonists, whereas there has been little enthusiasm for development of temporal aspects of glucoc
56  transcription factors support the continued enthusiasm for differentiation therapy of leukemia in th
57                         Provider and patient enthusiasm for frequent home nocturnal hemodialysis (FHN
58 activity, often as single agents, generating enthusiasm for further development in subgroups of patie
59  effect of lenalidomide, and results provide enthusiasm for further studies in AML, either alone or i
60                     Results suggest lessened enthusiasm for genetic information that maintains or inc
61 r these patients, and thus there has been an enthusiasm for getting patients to a point where liver r
62 ized with acute myocardial infarction (AMI), enthusiasm for glucose lowering is tempered, in part, by
63 es, and his continuous-and highly infectious-enthusiasm for his field, Peter Hochachka served as one
64 e system to clear tumors, generating renewed enthusiasm for identifying ways to induce antitumor immu
65 kpoint inhibition has led to a resurgence of enthusiasm for immunotherapy in the treatment of solid t
66 hesia or long recuperation times, has fueled enthusiasm for implantation.
67  landscape of pediatric cancer, there is now enthusiasm for individualized cancer therapy based on ge
68  (iPSC) technology has generated significant enthusiasm for its potential application in basic and tr
69  small numbers of adolescents generally show enthusiasm for its use among teens who are educated abou
70  associated with this procedure has dampened enthusiasm for its widespread use.
71  regression models testing associations with enthusiasm for key cost-containment strategies, having a
72                                        Thus, enthusiasm for LAAC as a treatment option has been appro
73                                          The enthusiasm for laparoscopic adjustable banding (LAGB) ha
74  reintroduction of smallpox, there is little enthusiasm for large-scale redeployment of licensed live
75 are thought to have contributed to decreased enthusiasm for LDLT.
76                              Despite initial enthusiasm for lemonade therapy, recent metabolic studie
77                                       Recent enthusiasm for limiting axillary lymph node dissection (
78  resistance and bone marrow toxicity limited enthusiasm for longer durations.
79                                   Widespread enthusiasm for low-intensity transcranial electrical cur
80                     Despite these obstacles, enthusiasm for lung gene therapy remains high.
81                 This study helps inspire new enthusiasm for making a grab for the proverbial two bird
82                                              Enthusiasm for malaria elimination has resurfaced.
83                                    A growing enthusiasm for minimally invasive surgical approaches an
84                                              Enthusiasm for multimodality approaches for gastric lymp
85                                Each surge in enthusiasm for new electrical treatments has been follow
86 mosphere of increasing and perhaps excessive enthusiasm for newer catheter-based interventions, it is
87 ted agents available for study has generated enthusiasm for oncologists treating thyroid cancer.
88 blication of this viewpoint will help temper enthusiasm for overzealous conversion of guidelines into
89                                 However, the enthusiasm for pan-HDAC inhibition in treating neurologi
90                                     Previous enthusiasm for permanent urethral stents has been dissip
91                                  The current enthusiasm for pharmacogenetics draws much of its inspir
92                                              Enthusiasm for photoangioplasty (PDT of vascular de novo
93 oint inhibitors as single agents has created enthusiasm for potential combinations with other cell-ba
94 stify human clinical trials and reinvigorate enthusiasm for radioimmunotherapy in the treatment of ma
95                                  The earlier enthusiasm for raising hemoglobin in heart failure has b
96                                              Enthusiasm for recombinant human erythropoietin (rhEPO)
97        As a consequence, there is continuing enthusiasm for retreating patients who did not achieve s
98 esearch to a general audience, and students' enthusiasm for science and their scientific knowledge ar
99 ne ovarian cancer screening, yet physicians' enthusiasm for several cancer screening tests before ben
100                                  The current enthusiasm for stratified medicine suggests that it may
101 nexus; significantly increasing or dampening enthusiasm for subsequent targets in the cancer immunoth
102 e Aurora kinase inhibitors has increased the enthusiasm for targeting these proteins in leukemia.
103 to the Vif-E3 Ub ligase complex and diminish enthusiasm for the amenability of APOBEC3 Ub acceptor si
104 ith acute coronary syndromes has renewed the enthusiasm for the cholesterol hypothesis and the hope t
105 releasing agents, has resulted in heightened enthusiasm for the clinical translation of this ephemera
106 c fibroblast growth factor (bFGF), generated enthusiasm for the concept that these agents might enhan
107                                              Enthusiasm for the development of Ca2+ sensitizers as in
108 stage of disease at diagnosis, there is much enthusiasm for the development of effective screening st
109                  Finally, there is continued enthusiasm for the development of NKT cell-based therapi
110 in bioengineering methodologies, have fueled enthusiasm for the development of stem cell-based lung t
111 mor antigens initially catalyzed substantial enthusiasm for the development of tumor antigen-based va
112                                              Enthusiasm for the enormous success of tyrosine kinase i
113  array of new approaches, are generating new enthusiasm for the immunotherapy of melanoma.
114  marker of coronary heart disease risk while enthusiasm for the importance of small dense LDL particl
115 gy have demonstrated feasibility and patient enthusiasm for the personalized medicine paradigm, but h
116 hibitor in AD patients has severely dampened enthusiasm for the potential of pursuing gamma-secretase
117                               There is great enthusiasm for the potential use of stem cells in treati
118                                       As the enthusiasm for the SLN technique has increased, our impr
119 tions of health benefits for children led to enthusiasm for the trial and for IPTc specifically.
120 al thoracic artery until the mid-1980s, when enthusiasm for the use of bilateral internal thoracic ar
121 d-free immunosuppressive regimen has renewed enthusiasm for the use of islet transplantation to treat
122                                              Enthusiasm for the use of monoclonal antibodies, such as
123                       There has been renewed enthusiasm for the use of niacin as second-line treatmen
124 pecific stem and progenitor cells and fueled enthusiasm for the use of such cells in strategies aimed
125  the toxicity for typical cadmium QDs limits enthusiasm for their clinical use.
126 ble pluripotent stem (iPS) cells has created enthusiasm for their potential applications in regenerat
127  exert direct antifibrotic effects, although enthusiasm for their use in patients has been tempered b
128 ytotoxicity and systemic side effects dampen enthusiasm for their use in sickle cell disease.
129                                Tempering the enthusiasm for their use, however-particularly in terms
130                                  The initial enthusiasm for these agents has been tempered by recogni
131                          Despite the current enthusiasm for these compounds several residual problems
132 that we can mobilize appropriate support and enthusiasm for these disciplines, are imagined.
133                                 The authors' enthusiasm for these drugs has diminished somewhat becau
134                                 However, the enthusiasm for these therapies has been tempered by tumo
135 paclitaxel in small-cell lung cancer dampens enthusiasm for this agent in the primary management of L
136                                     Clinical enthusiasm for this approach is strengthened by the many
137                                     However, enthusiasm for this approach is tempered by concerns tha
138  multiple clinical indications has reignited enthusiasm for this class of drugs.
139 f some beta-sheet proteins and have dampened enthusiasm for this model of protein folding.
140 n humanized mice suggest great potential and enthusiasm for this model to accelerate these critical a
141                                      Initial enthusiasm for this research was partially based on the
142                                              Enthusiasm for tolerance induction has been tempered by
143                 Disappointingly, the initial enthusiasm for transgenic mouse models of the disease ha
144 at early stage disease have led to new-found enthusiasm for treating and studying high-risk patients.
145               There has been recent clinical enthusiasm for treating short bowel patients with either
146 nt therapy trials, and (4) garnering patient enthusiasm for trial participation and involving them in
147 one replacement therapy is cardioprotective, enthusiasm for universal hormone replacement therapy in
148 ls on intravitreal biologic therapy for AMD, enthusiasm for vanguard biologic therapies should be tem
149 pturing the public imagination a decade ago, enthusiasm for VR flagged due to hardware limitations, a
150                                  Thus, great enthusiasm from early results and premature prediction m
151                                     However, enthusiasm has been muted by lack of direct evidence tha
152                                         This enthusiasm has been tempered by the observations that th
153                                              Enthusiasm has declined for sural nerve grafting because
154                                     Finally, enthusiasm has focused on the use of nonmyeloablative al
155 nsplantation, and these changes and clinical enthusiasm have been instrumental in achieving success.
156 case can be made for tempering the empirical enthusiasm here with a little more theoretical restraint
157  many of the STAIR guidelines, reinvigorated enthusiasm in neuroprotection, but the SAINT-II trial di
158 rapy trials in lung cancer, there is renewed enthusiasm in targeting the immune component of tumors.
159 ine of work that was investigated with great enthusiasm in the 1960s.
160 surgery has generated a tremendous amount of enthusiasm in the cardiology and cardiac surgical commun
161                                  Despite the enthusiasm in the field of biologic therapies, the major
162 EGFR) inhibitors was greeted with tremendous enthusiasm in the therapy of squamous cell carcinoma of
163                   With ever booming research enthusiasm in this field and increasing multidisciplinar
164 toxin-neutralizing antibodies in humans, but enthusiasm is dampened by its undefined composition, mul
165                                         This enthusiasm is driven by positive data in clinical trials
166                                In part, this enthusiasm is fueled through the diligence of numerous r
167                                     Although enthusiasm is growing for self-management programs for c
168 en structures, has continued with increasing enthusiasm, leading to two main fold classifications, SC
169 rganized and delivered with the aim to build enthusiasm, long term commitment and capacity in food co
170 ces in basic scientific understanding, early enthusiasm may be disproportionate to ultimate therapeut
171                         Despite considerable enthusiasm, mechanisms underlying the recognition of phe
172                      Furthermore, curiosity, enthusiasm, obstinacy, and paying attention to unexpecte
173 ues available to screen for BE, reducing the enthusiasm of gastroenterologists.
174 g in the preclinical years, the interest and enthusiasm of medical students for nutrition assessment
175 citing positive emotion such as contentment, enthusiasm or happiness.
176 oriatic arthritis has generated considerable enthusiasm regarding the therapeutic potential of these
177 The recent advances have inspired world-wide enthusiasm resulting in billions of dollars invested in
178                                         This enthusiasm should be tempered by the fact that the proba
179 ortunities abound for radiologists to revive enthusiasm, stimulate creativity, deepen their involveme
180  have entered an era of renewed interest and enthusiasm surrounding the diagnosis and treatment of va
181 eir discovery was received with a mixture of enthusiasm, suspicion and perplexity.
182                                Despite great enthusiasm, the impact of non-invasive brain stimulation
183          In conclusion and beyond reasonable enthusiasm, the mechanistic implementation and clinical
184                            After the initial enthusiasm, the study of personality disorder seems to b
185 te rapid clinical translation and widespread enthusiasm, the therapeutic benefits of adult bone marro
186                                       In our enthusiasm to advocate apoptosis as a therapeutic strate
187 lication have been largely overlooked in the enthusiasm to be the first to find new targets.
188              There has been a great level of enthusiasm to downregulate overactive N-methyl-D-asparta
189                                       Recent enthusiasm toward increased use of DCD donors' livers is
190 ome occupancy at the genome level, a renewed enthusiasm toward studying translation regulation is war
191 nding fields, there is the risk of excessive enthusiasm unless we are circumspect about the data that
192                          Nevertheless, early enthusiasm was tempered by controlled studies showing th
193       Scientists have responded with renewed enthusiasm, which has resulted in significant advances i
194 and sex-ratio conflicts, and defend that the enthusiasm with the latter has, in some cases, led to it

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top